Brequinar sodium
98%
- Product Code: 142816
CAS:
96201-88-6
| Molecular Weight: | 397.35 g./mol | Molecular Formula: | C₂₃H₁₄F₂NNaO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22648381 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Brequinar sodium is primarily used as an inhibitor of dihydroorotate dehydrogenase (DHODH), an enzyme involved in the de novo pyrimidine biosynthesis pathway. This action makes it a potent immunosuppressive agent, as rapidly dividing immune cells depend on this pathway for nucleotide supply. It has been investigated in organ transplantation to prevent graft rejection by suppressing T-cell proliferation.
In oncology, brequinar sodium shows potential as an anticancer agent due to its ability to limit nucleotide availability in fast-growing tumor cells. It has been studied in combination with other chemotherapeutics to enhance cytotoxic effects and overcome drug resistance.
Additionally, brequinar sodium has demonstrated antiviral activity, particularly against RNA viruses such as dengue, Zika, and influenza, by restricting the pool of pyrimidines needed for viral replication. This has led to interest in its use as a broad-spectrum antiviral therapeutic, especially in early-stage infection.
Research also explores its role in modulating cellular metabolism and immune responses in autoimmune diseases, highlighting its versatility beyond traditional chemotherapy and immunosuppression.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $175.61 |
+
-
|
| 0.025 | 10-20 days | $654.82 |
+
-
|
Brequinar sodium
Brequinar sodium is primarily used as an inhibitor of dihydroorotate dehydrogenase (DHODH), an enzyme involved in the de novo pyrimidine biosynthesis pathway. This action makes it a potent immunosuppressive agent, as rapidly dividing immune cells depend on this pathway for nucleotide supply. It has been investigated in organ transplantation to prevent graft rejection by suppressing T-cell proliferation.
In oncology, brequinar sodium shows potential as an anticancer agent due to its ability to limit nucleotide availability in fast-growing tumor cells. It has been studied in combination with other chemotherapeutics to enhance cytotoxic effects and overcome drug resistance.
Additionally, brequinar sodium has demonstrated antiviral activity, particularly against RNA viruses such as dengue, Zika, and influenza, by restricting the pool of pyrimidines needed for viral replication. This has led to interest in its use as a broad-spectrum antiviral therapeutic, especially in early-stage infection.
Research also explores its role in modulating cellular metabolism and immune responses in autoimmune diseases, highlighting its versatility beyond traditional chemotherapy and immunosuppression.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :